Next Article in Journal
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Next Article in Special Issue
Antiproliferative Properties of Type I and Type II Interferon
Previous Article in Journal
Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
Previous Article in Special Issue
Deregulation of Interferon Signaling in Malignant Cells
Article Menu

Export Article

Pharmaceuticals 2010, 3(4), 795-809; doi:10.3390/ph3040795
Open AccessReview

Notes on Article Versions

Action Date Notes Link
article html file updated 18 January 2013 03:44 CET Original file -
article html file updated 21 January 2013 21:51 CET Update -
article html file updated 25 January 2013 21:30 CET Update -
article html file updated 28 January 2013 18:39 CET Update -
article html file updated 5 February 2013 21:06 CET Update -
article html file updated 6 February 2013 16:56 CET Update -
article xml file uploaded 5 June 2014 08:48 CEST Original file -
article html file updated 5 June 2014 08:48 CEST Update -
article xml file uploaded 14 August 2014 12:04 CEST Update http://www.mdpi.com/1424-8247/3/4/795/xml
article html file updated 14 August 2014 12:04 CEST Update -
article html file updated 16 June 2015 08:49 CEST Update http://www.mdpi.com/1424-8247/3/4/795/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top